The bioinformatics sub-industry involves the use of software and algorithms to understand biological data. In 2024, big data and AI are increasingly used to accelerate drug discovery and development.
Cautious investment is suggested. There may be selective opportunities for turnaround specialists or those with high risk tolerance.